Orapred ODT 15 MG Disintegrating Oral Tablet
- RxCUI
- 647127
- RxNorm name
- Orapred ODT 15 MG Disintegrating Oral Tablet
- Display name
- Orapred ODT 15 MG Disintegrating Oral Tablet
- Full name
- Orapred ODT 15 MG Disintegrating Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Orapred ODT | PREDNISOLONE SODIUM PHOSPHATE | Advanz Pharma (US) Corp. | 1e379543-c4cf-4e72-953b-db15b7f0c2a1 | 2025-06-03 | Warnings, Adverse reactions | 647127 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1e379543-c4cf-4e72-953b-db15b7f0c2a1 | Orapred ODT 15 MG Disintegrating Oral Tablet | PSN | 12 | These highlights do not include all the information needed to use ORAPRED ODT ® safely and effectively. See full prescribing information for ORAPRED ODT ® . ORAPRED ODT ® (prednisolone sodium phosphate orally disintegrating tablets) Initial U.S. Approval: 1955 | 20250603 |
| 1e379543-c4cf-4e72-953b-db15b7f0c2a1 | Orapred 15 MG Disintegrating Oral Tablet | SY | 12 | These highlights do not include all the information needed to use ORAPRED ODT ® safely and effectively. See full prescribing information for ORAPRED ODT ® . ORAPRED ODT ® (prednisolone sodium phosphate orally disintegrating tablets) Initial U.S. Approval: 1955 | 20250603 |
| 1e379543-c4cf-4e72-953b-db15b7f0c2a1 | prednisolone 15 MG Disintegrating Oral Tablet [Orapred] | SBD | 12 | These highlights do not include all the information needed to use ORAPRED ODT ® safely and effectively. See full prescribing information for ORAPRED ODT ® . ORAPRED ODT ® (prednisolone sodium phosphate orally disintegrating tablets) Initial U.S. Approval: 1955 | 20250603 |